darbepoetin alfa
Selected indexed studies
- Darbepoetin alfa. (Drugs, 2001) [PMID:11735636]
- Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia: A Randomized, Double-Blind, Phase 3 Trial. (Clin J Am Soc Nephrol, 2020) [PMID:32723804]
- Darbepoetin alfa. Amgen. (Curr Opin Investig Drugs, 2001) [PMID:11892920]
_Worker-drafted node — pending editorial review._
Connections
darbepoetin alfa is a side effect of
Sources
- Darbepoetin alfa. (2001) pubmed
- Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia: A Randomized, Double-Blind, Phase 3 Trial. (2020) pubmed
- Darbepoetin alfa. Amgen. (2001) pubmed
- Pharmacology of darbepoetin alfa. (2007) pubmed
- Darbepoetin alfa: a novel erythropoiesis-stimulating protein. (2003) pubmed
- Darbepoetin alfa: in patients with chemotherapy-related anaemia. (2003) pubmed
- Darbepoetin alfa for anemia with myelodysplastic syndrome. (2015) pubmed
- Darbepoetin alfa: a new therapy for the management of anaemia associated with chronic kidney disease. (2002) pubmed
- Darbepoetin alfa in anemia of myelodysplastic syndromes: present and beyond. (2010) pubmed
- Darbepoetin alfa: an effective treatment with flexible and simplified dosing for anemia in patients with cancer. (2007) pubmed